144 related articles for article (PubMed ID: 37173367)
1. Design, synthesis and anticancer activities evaluation of novel pyrazole modified catalpol derivatives.
Kong Y; Liu S; Wang S; Yang B; He W; Li H; Yang S; Wang G; Dong C
Sci Rep; 2023 May; 13(1):7756. PubMed ID: 37173367
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis and Biological Evaluation of Novel Catalpol Derivatives as Potential Pancreatic Cancer Inhibitors.
Kong Y; Liu S; Wang S; Xu J; Hu Y; Jiang S; Dong C
Chem Asian J; 2023 Jun; 18(12):e202300185. PubMed ID: 37129956
[TBL] [Abstract][Full Text] [Related]
3. Bioactivities of Natural Catalpol Derivatives.
Zhang LQ; Chen KX; Li YM
Curr Med Chem; 2019; 26(33):6149-6173. PubMed ID: 31218947
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, and Biological Evaluation of Novel Thiazolyl Substituted Bis-pyrazole Oxime Derivatives with Potent Antitumor Activities by Selectively Inducing Apoptosis and ROS in Cancer Cells.
Xiong B; Chen S; Zhu P; Huang M; Gao W; Zhu R; Qian J; Peng Y; Zhang Y; Dai H; Ling Y
Med Chem; 2019; 15(7):743-754. PubMed ID: 30147012
[TBL] [Abstract][Full Text] [Related]
5. Design, microwave synthesis, and molecular docking studies of catalpol crotonates as potential neuroprotective agent of diabetic encephalopathy.
Liu S; Cheng X; Li X; Kong Y; Jiang S; Dong C; Wang G
Sci Rep; 2020 Nov; 10(1):20415. PubMed ID: 33230173
[TBL] [Abstract][Full Text] [Related]
6. Multiple Biological Effects of an Iridoid Glucoside, Catalpol and Its Underlying Molecular Mechanisms.
Bhattamisra SK; Yap KH; Rao V; Choudhury H
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31878316
[TBL] [Abstract][Full Text] [Related]
7. Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways.
El-Hanboshy SM; Helmy MW; Abd-Alhaseeb MM
Mol Biol Rep; 2021 Nov; 48(11):7233-7242. PubMed ID: 34596810
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic potential of catalpol and geniposide in Alzheimer's and Parkinson's diseases: A snapshot of their underlying mechanisms.
Zhang X; Liu K; Shi M; Xie L; Deng M; Chen H; Li X
Brain Res Bull; 2021 Sep; 174():281-295. PubMed ID: 34216649
[TBL] [Abstract][Full Text] [Related]
9. Catalpol Inhibited the Proliferation of T24 Human Bladder Cancer Cells by Inducing Apoptosis Through the Blockade of Akt-Mediated Anti-apoptotic Signaling.
Jin D; Cao M; Mu X; Yang G; Xue W; Huang Y; Chen H
Cell Biochem Biophys; 2015 Apr; 71(3):1349-56. PubMed ID: 25388838
[TBL] [Abstract][Full Text] [Related]
10. Catalpol induces apoptosis in breast cancer in vitro and in vivo: Involvement of mitochondria apoptosis pathway and post-translational modifications.
Liu J; Du J; Li Y; Wang F; Song D; Lin J; Li B; Li L
Toxicol Appl Pharmacol; 2022 Nov; 454():116215. PubMed ID: 36067808
[TBL] [Abstract][Full Text] [Related]
11. Effect of madecassoside and catalpol in amelioration of insulin sensitivity in pancreatic (INS-1E) β-cell line.
Elhassan SAM; Candasamy M; Ching TS; Heng YK; Bhattamisra SK
Nat Prod Res; 2021 Nov; 35(22):4627-4631. PubMed ID: 31797687
[TBL] [Abstract][Full Text] [Related]
12. [Study on distribution and dynamic accumulation of catalpol and total iridoid in fresh Rehmannia glutinosa].
Ji XQ; Sun P; Qi JJ; Liao DQ; Li XE
Zhongguo Zhong Yao Za Zhi; 2014 Feb; 39(3):466-70. PubMed ID: 24946549
[TBL] [Abstract][Full Text] [Related]
13. Catalpol suppressed proliferation, growth and invasion of CT26 colon cancer by inhibiting inflammation and tumor angiogenesis.
Zhu P; Wu Y; Yang A; Fu X; Mao M; Liu Z
Biomed Pharmacother; 2017 Nov; 95():68-76. PubMed ID: 28826099
[TBL] [Abstract][Full Text] [Related]
14. Catalpol‑mediated microRNA‑34a suppresses autophagy and malignancy by regulating SIRT1 in colorectal cancer.
Qiao PF; Yao L; Zeng ZL
Oncol Rep; 2020 Apr; 43(4):1053-1066. PubMed ID: 32323786
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effect and mechanism of catalpol in various inflammatory diseases.
Liu J; Liu S; Yu M; Li J; Xie Z; Gao B; Liu Y
Drug Dev Res; 2023 Nov; 84(7):1376-1394. PubMed ID: 37534768
[TBL] [Abstract][Full Text] [Related]
16. Triarylpyrazole Derivatives as Potent Cytotoxic Agents; Synthesis and Bioactivity Evaluation "Pyrazole Derivatives as Anticancer Agent".
Sameem B; Moghadam ES; Darabi M; Shahsavari Z; Amini M
Drug Res (Stuttg); 2021 Sep; 71(7):388-394. PubMed ID: 34010979
[TBL] [Abstract][Full Text] [Related]
17. Catalpol inhibits migration and induces apoptosis in gastric cancer cells and in athymic nude mice.
Wang ZH; Zhan-Sheng H
Biomed Pharmacother; 2018 Jul; 103():1708-1719. PubMed ID: 29864961
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of inhibitory effect of catalpol on TNF-α induced HAECs cell damage].
Xu CY; Zhang YK; Sun HJ; Zhang H
Zhongguo Zhong Yao Za Zhi; 2019 Feb; 44(4):796-802. PubMed ID: 30989894
[TBL] [Abstract][Full Text] [Related]
19. Polymer microspheres modified with pyrazole derivatives as potential agents in anticancer therapy - Preliminary studies.
Podkościelna B; Klimek K; Karczmarzyk Z; Wysocki W; Brodacka M; Serafin K; Kozyra P; Kowalczuk D; Ginalska G; Pitucha M
Bioorg Chem; 2022 Jun; 123():105765. PubMed ID: 35427940
[TBL] [Abstract][Full Text] [Related]
20. Review of the Ethnopharmacology, Phytochemistry, and Pharmacology of the Genus
Xue H; Chen KX; Zhang LQ; Li YM
Am J Chin Med; 2019; 47(6):1193-1221. PubMed ID: 31488038
[No Abstract] [Full Text] [Related]
[Next] [New Search]
